naltrexone has been researched along with 4-hydroxybutyric acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Addolorato, G; Bernardi, M; Caputo, F; del RE, A; Domenicali, M; Gasbarrini, G; Greco, G; Lorenzini, F; Stefanini, GF | 1 |
| Bernardi, M; Caputo, F; Francini, S; Stoppo, M; Vignoli, T | 1 |
| Addolorato, G; Berrino, L; Capuano, A; Maione, S; Rinaldi, B; Rossi, F; Stella, L | 1 |
| Diouf, M; González-Marín, MC; Jeanblanc, J; Lebourgeois, S; Naassila, M | 1 |
1 review(s) available for naltrexone and 4-hydroxybutyric acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for naltrexone and 4-hydroxybutyric acid
| Article | Year |
|---|---|
Gamma-hydroxybutyric acid versus naltrexone in maintaining alcohol abstinence: an open randomized comparative study.
Topics: Alcohol Drinking; Alcoholism; Female; Humans; Hydroxybutyrates; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Temperance; Time Factors; Treatment Outcome | 2003 |
An open randomized study of the treatment of escitalopram alone and combined with gamma-hydroxybutyric acid and naltrexone in alcoholic patients.
Topics: Adult; Alcoholism; Citalopram; Drug Therapy, Combination; Female; Humans; Hydroxybutyrates; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Selective Serotonin Reuptake Inhibitors | 2008 |
2 other study(ies) available for naltrexone and 4-hydroxybutyric acid
| Article | Year |
|---|---|
GABAergic medications for treating alcohol dependence.
Topics: Alcoholism; Baclofen; Drug Therapy, Combination; GABA Agonists; gamma-Aminobutyric Acid; Humans; Hydroxybutyrates; Naltrexone; Narcotic Antagonists; Randomized Controlled Trials as Topic; Receptors, GABA-B; Substance Withdrawal Syndrome; Temperance | 2007 |
Evaluation of alcohol use disorders pharmacotherapies in a new preclinical model of binge drinking.
Topics: Acamprosate; Animals; Baclofen; Binge Drinking; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Extinction, Psychological; Hydroxybutyrates; Male; Motivation; Naltrexone; Rats; Self Administration | 2018 |